Using chatbots to screen for heritable cancer syndromes in patients undergoing routine colonoscopy
The DOI matches its Crossref record.
Abstract
Background: Hereditary colorectal cancer (HCRC) syndromes account for 10% of colorectal cancers but remain underdiagnosed. This feasibility project tested the utility of an artificial intelligence-based chatbot deployed to patients scheduled for colonoscopy to identify HCRC risk factors, educate participants about HCRC and obtain consent to genetic testing as an extension of genetic counselling of appropriate subjects. Genetic counsellor (GC) and genetic counselling assistant (GCA) time spent per subject was also measured. Methods: Patients scheduled for colonoscopy at Cleveland Clinic were invited via electronic medical record patient portal or letter prior to colonoscopy with a link to a chatbot administering the Colon Cancer Risk Assessment Tool (CCRAT) to screen for HCRC syndromes. Those with ≥1 positive response to a CCRAT question received chatbot-deployed genetic education and the option to receive genetic testing. An order for a 55-gene pan-cancer panel was placed for those consenting, and the subject had blood drawn on the day of colonoscopy. Results were disclosed by a GC or GCA by telephone. Subject demographics, progression through the chat, responses to CCRAT, personal and family history, genetic test results and communication with the subject were recorded. Descriptive statistics and two-tailed unpaired t-test and Fisher’s exact test were used. Results: 506/4254 (11.9%) initiated and 487 (96.2%) completed the chat with the chatbot. 215 (44.1%) answered ‘yes’ to ≥1 CCRAT question and all completed pretest education. 129/181 (71.3%) subjects who consented completed testing, and 12 (9.3%) were found to have a germline pathogenic variant. Per subject, the GC spent a mean of 14.3 (SD 7.3) and the GCA a mean of 19.2 (SD 9.8) minutes. Conclusion: The use of a chatbot in this setting was a novel and feasible method, with the potential of increasing genetic screening and testing in individuals at risk of HCRC syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hindelang, M., Sitaru, S., & Zink, A. (2024) · JMIR Medical Informatics · doi:10.2196/56628 · Cited by 79
The Use of Chatbots in Oncological Care: A Narrative Review
Wang, A., Qian, Z., Briggs, L., Cole, A. P., Reis, L. O., & Trinh, Q.-D. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s408208 · Cited by 73
Al-Hilli, Z., Noss, R., Dickard, J., Wei, W., Chichura, A., Wu, V., Renicker, K., Pederson, H. J., & Eng, C. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13888-4 · Cited by 63
Self-citationvan Bussel, M. J. P., Odekerken–Schröder, G. J., Ou, C., Swart, R. R., & Jacobs, M. J. G. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08189-7 · Cited by 60
“With regards to cancer diseases, self-diagnosis VAs were used for genetic counselling in two studies [26, 27] that report a VA’s viability to assess hereditary cancer risk by querying participants’ family history.”
MethodSiglen, E., Vetti, H. H., Augestad, M., Steen, V. M., Lunde, Å., & Bjorvatn, C. (2023) · Journal of Medical Internet Research · doi:10.2196/46571 · Cited by 33
“In medical genetics, chatbots are already used to assist different aspects, such as identifying patients at risk of hereditary colorectal cancer syndromes [7], collecting family health history [8], and collecting and providing genomic information before or after pretest consultations [9].”
Metadata
- Authors
- Heald, B., Keel, E., Marquard, J., Burke, C. A., Kalady, M. F., Church, J. M., Liska, D., Mankaney, G., Hurley, K., & Eng, C.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2020-11-09
- Volume
- 58
- Issue
- 12
- Pages
- 807-814
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W3102663258
- Cited by
- 55
- References
- 0
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Using chatbots to screen for heritable cancer syndromes in patients undergoing routine colonoscopy. https://app.cochat.ai/papers/10.1136/jmedgenet-2020-107294
- The paper
- Heald, B., Keel, E., Marquard, J., Burke, C. A., Kalady, M. F., Church, J. M., Liska, D., Mankaney, G., Hurley, K., & Eng, C. (2021). Using chatbots to screen for heritable cancer syndromes in patients undergoing routine colonoscopy. Journal of Medical Genetics. https://doi.org/10.1136/jmedgenet-2020-107294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.